# Association of Thoraco-mediastinal Radiotherapy With Maintenance Immunotherapy Treatment With Atezolizumab

> **NCT06771518** · PHASE2 · RECRUITING · sponsor: **Regina Elena Cancer Institute** · enrollment: 37 (estimated)

## Conditions studied

- Small Cell Lung Cancer

## Interventions

- **RADIATION:** Thoracic radiotherapy
- **DRUG:** Atezolizumab 1200 mg e.v. q21

## Key facts

- **NCT ID:** NCT06771518
- **Lead sponsor:** Regina Elena Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-12-15
- **Primary completion:** 2026-12-15
- **Final completion:** 2026-12-15
- **Target enrollment:** 37 (ESTIMATED)
- **Last updated:** 2025-01-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06771518

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06771518, "Association of Thoraco-mediastinal Radiotherapy With Maintenance Immunotherapy Treatment With Atezolizumab". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06771518. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*